Oakland, CA, United States of America

Nicholas A Be

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Lawrence Livermore National Security, LLC. Active years: 2020-2021.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Nicholas A Be

Introduction

Nicholas A Be is a notable inventor based in Oakland, CA. He has made significant contributions to the field of chemistry, particularly in the development of compounds that address the challenges posed by organophosphorus-based compounds. With a total of 2 patents, his work is crucial for therapeutic applications and decontamination processes.

Latest Patents

Nicholas A Be's latest patents include innovative compounds for the central reactivation of organophosphorus-based compound-inhibited acetylcholinesterase. These compounds are designed to cross the blood-brain barrier and reactivate inhibited acetylcholinesterase, providing therapeutic and prophylactic treatment options. His second patent focuses on oxime compounds capable of inactivating nerve agents, which also penetrate the blood-brain barrier and reactivate acetylcholinesterase. Both patents highlight methods, systems, and compositions for the inactivation of harmful agents and the decontamination of affected individuals.

Career Highlights

Nicholas A Be is associated with Lawrence Livermore National Security, LLC, where he applies his expertise in chemistry to develop life-saving technologies. His work is instrumental in advancing the understanding and treatment of chemical exposures.

Collaborations

Some of his notable coworkers include Carlos A Valdez and Brian J Bennion, who contribute to the collaborative efforts in research and development at their organization.

Conclusion

Nicholas A Be's innovative work in the field of chemistry, particularly regarding organophosphorus compounds, showcases his dedication to improving safety and health outcomes. His patents reflect a commitment to addressing critical challenges in chemical exposure and treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…